Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04GKP
|
|||
| Former ID |
DIB012406
|
|||
| Drug Name |
AS-902330
|
|||
| Synonyms |
Sprifermin; Zfgf5; FGF-18, Merck Serono; FGF-18, ZymoGenetics
Click to Show/Hide
|
|||
| Indication | Arthropathy [ICD-11: FA11-FA38; ICD-10: M00-M14] | Phase 2 | [1] | |
| Company |
Emd serono
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01919164) A Study to Investigate the Safety and Effectiveness of Different Doses of Sprifermin (AS902330) in Patients With Osteoarthritis of the Knee. U.S. National Institutes of Health. | |||
| REF 2 | Intraarticular sprifermin (recombinant human fibroblast growth factor 18) in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial. Arthritis Rheumatol. 2014 Jul;66(7):1820-31. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.